Cargando…

The lungs were on fire: a pilot study of (18)F-FDG PET/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease

BACKGROUND: Interstitial lung disease (ILD) and its rapid progression (RP) are the main contributors to unfavourable outcomes of patients with idiopathic inflammatory myopathy (IIM). This study aimed to identify the clinical value of PET/CT scans in IIM-ILD patients and to construct a predictive mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Junyu, Cao, Heng, Liu, Yinuo, Ye, Bingjue, Sun, Yiduo, Ke, Yini, He, Ye, Xu, Bei, Lin, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298695/
https://www.ncbi.nlm.nih.gov/pubmed/34301306
http://dx.doi.org/10.1186/s13075-021-02578-9
_version_ 1783726112463912960
author Liang, Junyu
Cao, Heng
Liu, Yinuo
Ye, Bingjue
Sun, Yiduo
Ke, Yini
He, Ye
Xu, Bei
Lin, Jin
author_facet Liang, Junyu
Cao, Heng
Liu, Yinuo
Ye, Bingjue
Sun, Yiduo
Ke, Yini
He, Ye
Xu, Bei
Lin, Jin
author_sort Liang, Junyu
collection PubMed
description BACKGROUND: Interstitial lung disease (ILD) and its rapid progression (RP) are the main contributors to unfavourable outcomes of patients with idiopathic inflammatory myopathy (IIM). This study aimed to identify the clinical value of PET/CT scans in IIM-ILD patients and to construct a predictive model for RP-ILD. METHODS: Adult IIM-ILD patients who were hospitalized at four divisions of the First Affiliated Hospital, Zhejiang University School of Medicine (FAHZJU), from 1 January 2017 to 31 December 2020 were reviewed. PET/CT scans and other characteristics of patients who met the inclusion and exclusion criteria were collected and analysed. RESULTS: A total of 61 IIM-ILD patients were enrolled in this study. Twenty-one patients (34.4%) developed RP-ILD, and 24 patients (39.3%) died during follow-up. After false discovery rate (FDR) correction, the percent-predicted diffusing capacity of the lung for carbon monoxide (DLCO%, P = 0.014), bilateral lung mean standard uptake value (SUVmean, P = 0.014) and abnormal mediastinal lymph node (P = 0.045) were significantly different between the RP-ILD and non-RP-ILD groups. The subsequent univariate and multivariate logistic regression analyses verified our findings. A “DLM” model was established by including the above three values to predict RP-ILD with a cut-off value of ≥ 2 and an area under the curve (AUC) of 0.905. Higher bilateral lung SUVmean (P = 0.019) and spleen SUVmean (P = 0.011) were observed in IIM-ILD patients who died within 3 months, and a moderate correlation was recognized between the two values. CONCLUSIONS: Elevated bilateral lung SUVmean, abnormal mediastinal lymph nodes and decreased DLCO% were significantly associated with RP-ILD in IIM-ILD patients. The “DLM” model was valuable in predicting RP-ILD and requires further validation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02578-9.
format Online
Article
Text
id pubmed-8298695
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82986952021-07-23 The lungs were on fire: a pilot study of (18)F-FDG PET/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease Liang, Junyu Cao, Heng Liu, Yinuo Ye, Bingjue Sun, Yiduo Ke, Yini He, Ye Xu, Bei Lin, Jin Arthritis Res Ther Research Article BACKGROUND: Interstitial lung disease (ILD) and its rapid progression (RP) are the main contributors to unfavourable outcomes of patients with idiopathic inflammatory myopathy (IIM). This study aimed to identify the clinical value of PET/CT scans in IIM-ILD patients and to construct a predictive model for RP-ILD. METHODS: Adult IIM-ILD patients who were hospitalized at four divisions of the First Affiliated Hospital, Zhejiang University School of Medicine (FAHZJU), from 1 January 2017 to 31 December 2020 were reviewed. PET/CT scans and other characteristics of patients who met the inclusion and exclusion criteria were collected and analysed. RESULTS: A total of 61 IIM-ILD patients were enrolled in this study. Twenty-one patients (34.4%) developed RP-ILD, and 24 patients (39.3%) died during follow-up. After false discovery rate (FDR) correction, the percent-predicted diffusing capacity of the lung for carbon monoxide (DLCO%, P = 0.014), bilateral lung mean standard uptake value (SUVmean, P = 0.014) and abnormal mediastinal lymph node (P = 0.045) were significantly different between the RP-ILD and non-RP-ILD groups. The subsequent univariate and multivariate logistic regression analyses verified our findings. A “DLM” model was established by including the above three values to predict RP-ILD with a cut-off value of ≥ 2 and an area under the curve (AUC) of 0.905. Higher bilateral lung SUVmean (P = 0.019) and spleen SUVmean (P = 0.011) were observed in IIM-ILD patients who died within 3 months, and a moderate correlation was recognized between the two values. CONCLUSIONS: Elevated bilateral lung SUVmean, abnormal mediastinal lymph nodes and decreased DLCO% were significantly associated with RP-ILD in IIM-ILD patients. The “DLM” model was valuable in predicting RP-ILD and requires further validation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02578-9. BioMed Central 2021-07-23 2021 /pmc/articles/PMC8298695/ /pubmed/34301306 http://dx.doi.org/10.1186/s13075-021-02578-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Liang, Junyu
Cao, Heng
Liu, Yinuo
Ye, Bingjue
Sun, Yiduo
Ke, Yini
He, Ye
Xu, Bei
Lin, Jin
The lungs were on fire: a pilot study of (18)F-FDG PET/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease
title The lungs were on fire: a pilot study of (18)F-FDG PET/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease
title_full The lungs were on fire: a pilot study of (18)F-FDG PET/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease
title_fullStr The lungs were on fire: a pilot study of (18)F-FDG PET/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease
title_full_unstemmed The lungs were on fire: a pilot study of (18)F-FDG PET/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease
title_short The lungs were on fire: a pilot study of (18)F-FDG PET/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease
title_sort lungs were on fire: a pilot study of (18)f-fdg pet/ct in idiopathic-inflammatory-myopathy-related interstitial lung disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298695/
https://www.ncbi.nlm.nih.gov/pubmed/34301306
http://dx.doi.org/10.1186/s13075-021-02578-9
work_keys_str_mv AT liangjunyu thelungswereonfireapilotstudyof18ffdgpetctinidiopathicinflammatorymyopathyrelatedinterstitiallungdisease
AT caoheng thelungswereonfireapilotstudyof18ffdgpetctinidiopathicinflammatorymyopathyrelatedinterstitiallungdisease
AT liuyinuo thelungswereonfireapilotstudyof18ffdgpetctinidiopathicinflammatorymyopathyrelatedinterstitiallungdisease
AT yebingjue thelungswereonfireapilotstudyof18ffdgpetctinidiopathicinflammatorymyopathyrelatedinterstitiallungdisease
AT sunyiduo thelungswereonfireapilotstudyof18ffdgpetctinidiopathicinflammatorymyopathyrelatedinterstitiallungdisease
AT keyini thelungswereonfireapilotstudyof18ffdgpetctinidiopathicinflammatorymyopathyrelatedinterstitiallungdisease
AT heye thelungswereonfireapilotstudyof18ffdgpetctinidiopathicinflammatorymyopathyrelatedinterstitiallungdisease
AT xubei thelungswereonfireapilotstudyof18ffdgpetctinidiopathicinflammatorymyopathyrelatedinterstitiallungdisease
AT linjin thelungswereonfireapilotstudyof18ffdgpetctinidiopathicinflammatorymyopathyrelatedinterstitiallungdisease
AT liangjunyu lungswereonfireapilotstudyof18ffdgpetctinidiopathicinflammatorymyopathyrelatedinterstitiallungdisease
AT caoheng lungswereonfireapilotstudyof18ffdgpetctinidiopathicinflammatorymyopathyrelatedinterstitiallungdisease
AT liuyinuo lungswereonfireapilotstudyof18ffdgpetctinidiopathicinflammatorymyopathyrelatedinterstitiallungdisease
AT yebingjue lungswereonfireapilotstudyof18ffdgpetctinidiopathicinflammatorymyopathyrelatedinterstitiallungdisease
AT sunyiduo lungswereonfireapilotstudyof18ffdgpetctinidiopathicinflammatorymyopathyrelatedinterstitiallungdisease
AT keyini lungswereonfireapilotstudyof18ffdgpetctinidiopathicinflammatorymyopathyrelatedinterstitiallungdisease
AT heye lungswereonfireapilotstudyof18ffdgpetctinidiopathicinflammatorymyopathyrelatedinterstitiallungdisease
AT xubei lungswereonfireapilotstudyof18ffdgpetctinidiopathicinflammatorymyopathyrelatedinterstitiallungdisease
AT linjin lungswereonfireapilotstudyof18ffdgpetctinidiopathicinflammatorymyopathyrelatedinterstitiallungdisease